[go: up one dir, main page]

AU4980100A - Compositions containing benzimidazolones and progestogens - Google Patents

Compositions containing benzimidazolones and progestogens

Info

Publication number
AU4980100A
AU4980100A AU49801/00A AU4980100A AU4980100A AU 4980100 A AU4980100 A AU 4980100A AU 49801/00 A AU49801/00 A AU 49801/00A AU 4980100 A AU4980100 A AU 4980100A AU 4980100 A AU4980100 A AU 4980100A
Authority
AU
Australia
Prior art keywords
benzimidazolones
progestogens
compositions containing
compositions
containing benzimidazolones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49801/00A
Inventor
Reinhold H. W. Bender
James P. Edwards
Gary S Grubb
Todd K. Jones
Christopher M Tegley
Jay E. Wrobel
Puwen Zhang
Lin Zhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Ligand Pharmaceuticals Inc
Original Assignee
Ligand Pharmaceuticals Inc
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,355 external-priority patent/US6423699B1/en
Application filed by Ligand Pharmaceuticals Inc, American Home Products Corp filed Critical Ligand Pharmaceuticals Inc
Publication of AU4980100A publication Critical patent/AU4980100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU49801/00A 1999-05-04 2000-05-01 Compositions containing benzimidazolones and progestogens Abandoned AU4980100A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60198249 1999-05-04
US09552355 2000-04-19
US09/552,355 US6423699B1 (en) 1999-05-04 2000-04-19 Combination therapies using benzimidazolones
PCT/US2000/011845 WO2000066168A1 (en) 1999-05-04 2000-05-01 Compositions containing benzimidazolones and progestogens

Publications (1)

Publication Number Publication Date
AU4980100A true AU4980100A (en) 2000-11-17

Family

ID=24204973

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49801/00A Abandoned AU4980100A (en) 1999-05-04 2000-05-01 Compositions containing benzimidazolones and progestogens

Country Status (3)

Country Link
EP (1) EP1173213A1 (en)
AU (1) AU4980100A (en)
WO (1) WO2000066168A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003258050A1 (en) 2002-10-11 2004-05-04 Ligand Pharmaceuticals Incorporated 5-cycloalkenyl 5h-chromeno(3,4-f)quinoline derivatives as selective progesterone receptor modulator compounds
MXPA05003800A (en) 2002-10-11 2005-06-08 Ligand Pharm Inc 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5h.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (en) * 1987-10-01 1989-04-13 Schering Ag ANTIGESTAGEN AND ANTIOOTROGENIC COMPOUNDS FOR THE INTRODUCTION OF BIRTH AND PREGNANCY, AND THE TREATMENT OF GYNAECOLOGICAL DISORDER AND HORMONE-RELATED TUMORS
DE4330234A1 (en) * 1993-09-02 1995-03-09 Schering Ag The use of progestogens and competitive progesterone antagonists for the production of pharmaceuticals for female fertility control and compositions comprising a progestogen and a competitive progesterone antagonist
DE4344463A1 (en) * 1993-12-22 1995-06-29 Schering Ag Combination product for contraception
EP1488794A3 (en) * 1994-11-22 2005-04-20 Balance Pharmaceuticals, Inc. Methods of contraception
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
ATE213947T1 (en) * 1996-06-25 2002-03-15 Akzo Nobel Nv PROGESTOGEN-ANTI-PROGESTOGEN THERAPIES

Also Published As

Publication number Publication date
WO2000066168A1 (en) 2000-11-09
EP1173213A1 (en) 2002-01-23

Similar Documents

Publication Publication Date Title
AU5634300A (en) Composition and films thereof
AU3731600A (en) Composition and structures made therefrom
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU3233400A (en) Fire suppression composition and device
HUP0200797A3 (en) Releasable linkage and compositions containing same
AU4198299A (en) Compounds and uses thereof
AU2349399A (en) R-lansoprazole compositions and methods
AU5565099A (en) Pharmaceutical compositions and methods for use
AU1403501A (en) Novel composition and use
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
AU7651100A (en) Pharmaceutical and/or cosmetical compositions
AU4834200A (en) Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
MXPA01011309A (en) Compositions containing benzimidazolones and progestogens.
AU7816000A (en) Pediculocidal and veterinary compositions
AU5384699A (en) Basic peptides and pharmaceutical compositions containing same
AU7853700A (en) Foams and compositions containing these foams
AU1152601A (en) Compositions and their use
AU6297700A (en) Organometallic compositions and polyisocyanate compositions containing them
AU2183899A (en) Isoflavane derivatives and immunopotentiating compositions containing the same
IL146047A0 (en) Releasable linkage and compositions containing same
AU4543500A (en) Pharmaceutical compositions and uses
AU7681498A (en) Pharmaceutical composition and use thereof
AUPO982097A0 (en) Methods and compositions for use therein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase